Clinical Trials Directory

Trials / Completed

CompletedNCT05883150

Intranasal Versus Nebulized Midazolam in Behaviuor Modification of Preschool Children Undergoing Dental Treatment

Intranasal Versus Nebulized Midazolam in Behaviuor Modification of Preschool Children Undergoing Dental Treatment: A Randomized Clinical Trial

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
68 (actual)
Sponsor
Nourhan M.Aly · Academic / Other
Sex
All
Age
3 Years – 6 Years
Healthy volunteers
Not accepted

Summary

The aim of the current study is to compare the effect of intranasal versus nebulized route of administration of midazolam as moderate sedative agents in preschoolers undergoing dental treatment.

Conditions

Interventions

TypeNameDescription
DRUGNebulized MidazolamAll the drug solutions will be freshly prepared on the day of sedation session. Depending on the dosage calculated from the weight of each child The sedative drug, the dosage will be diluted with an equal volume by adding distilled water. The child will be seated in an upright position on the dental chair. Before placing the mask of the nebulizer, the child will be coached into proper breathing pattern
DRUGIntranasal MidazolamAll the drug solutions will be freshly prepared on the day of sedation session. Depending on the dosage calculated from the weight of each child, For children who will receive midazolam using the atomization device attached to a three-ml syringe, the child sitting reclined in knee-to-knee position. Half of the dose will be sprayed in the right nostril and the other half will be sprayed in the left nostril to double the absorptive surface area by short and quick puffs

Timeline

Start date
2022-11-10
Primary completion
2023-08-30
Completion
2023-08-30
First posted
2023-05-31
Last updated
2023-11-21

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05883150. Inclusion in this directory is not an endorsement.